Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma

NCT00585078 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: Capecitabine
DRUG: Oxaliplatin

Sponsor

Beth Israel Deaconess Medical Center

Collaborators

[object Object]